The University of Tokyo Edge Capital

Piece is a platform for investing in rented properties, offering monthly rental income and long-term appreciation for everyone.

Aerem is a FinTech platform that facilitates the adoption of rooftop solar systems for businesses, reducing electricity costs by up to 70%. It leverages a wide installer network and offers quick loans through its in-house NBFC or partner banks. Headquartered in Mumbai, Aerem aims to democratize clean energy adoption and create a sustainable future.

TriOrb is a technology company focused on the development of advanced robotic mobility solutions. It designs and engineers a unique movement system that features a ball-driven omnidirectional mechanism, enabling robots to navigate and transport various objects in manufacturing environments. This innovative technology enhances efficiency and safety on production lines by allowing multiple robots to work together cooperatively, thereby improving the transportation of items that cannot be handled by a single unit. Through its integration of software and hardware, TriOrb aims to provide manufacturers with effective robotic solutions that streamline operations and optimize productivity.

RegCell is a biotechnology company focused on developing innovative therapeutic technologies to address autoimmune diseases and cancer. The company specializes in creating advanced cell therapies that work by controlling and augmenting the immune system. RegCell's approach involves returning regulatory T cells and activating them in vitro, allowing for effective treatment options for patients facing these challenging health conditions. By targeting unmet medical needs, RegCell aims to improve patient outcomes and provide new hope for those suffering from autoimmune disorders and cancer.

Issin develops a smart health monitoring device for personal health management. The device provides weight measurement, body composition analysis, and personalized health recommendations, enabling healthcare professionals to help clients track health metrics and make informed decisions for a healthier lifestyle.

Eureka Robotics specializes in developing robotic technology that offers high accuracy and agility. With offices in Singapore, France, and Vietnam, it serves various industries such as healthcare, telecom, automotive, photonics, electronics, optics, and aerospace by automating precision handling, assembly, inspection tasks. Its software and systems enable clients to enhance productivity, reduce costs, and improve safety.

Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.

Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It specializes in digital transformation within the commercial real estate sector, offering a software as a service (SaaS) platform that enhances the flow of information and transactions. Estie provides a range of services, including market research and algorithms for rent estimation, which help clients make informed, data-driven decisions. By leveraging innovative software solutions, Estie aims to unlock the value of the commercial real estate industry, facilitating a more efficient and effective decision-making process for its users.

SUN METALON specializes in decarbonizing metal manufacturing by offering innovative technology for recycling, refining, and forming metals. Its core innovation lies in efficient heating of metal scraps and chips, reducing energy consumption and impurities, thereby significantly lowering CO₂ emissions compared to traditional methods.

TriOrb is a technology company focused on the development of advanced robotic mobility solutions. It designs and engineers a unique movement system that features a ball-driven omnidirectional mechanism, enabling robots to navigate and transport various objects in manufacturing environments. This innovative technology enhances efficiency and safety on production lines by allowing multiple robots to work together cooperatively, thereby improving the transportation of items that cannot be handled by a single unit. Through its integration of software and hardware, TriOrb aims to provide manufacturers with effective robotic solutions that streamline operations and optimize productivity.

Quanmatic is a technology company specializing in algorithm development to bridge quantum technologies. It offers an experiential learning platform that provides tutorial content and demo applications for combinatorial optimization problems, supporting mathematical input and web-based annealing machine operations.

Celaid Therapeutics specializes in the development and commercialization of regenerative medicine products. Its platform focuses on creating medicines using human hematopoietic stem cell expansion technology, supporting research for media reagents, and facilitating hematopoietic stem cell transplantation.

Red Arrow Therapeutics develops a healthcare technology that replaces conventional cancer treatments. The company focuses on next‑generation therapies that enhance drug potency while reducing toxicity, aiming to improve outcomes across various tumor models, both as monotherapy and in combination with immune checkpoint inhibitors.

SWAT Mobility is a developer of advanced vehicle-routing technology that addresses intricate transportation challenges faced by companies, transport operators, and government agencies globally. Utilizing an artificial intelligence algorithm, the company specializes in optimizing route planning for large-scale transportation by enabling vehicle pooling and dynamic route adjustments. This innovative approach has been shown to significantly reduce transportation costs, enhance connectivity within cities, and alleviate traffic congestion. SWAT Mobility has established itself as a leader in the industry, demonstrating superior performance through its smart mobility optimization engine, which positions it well for future advancements in autonomous vehicle technology.

X Mile is an HR platform that connects logistics companies with drivers, aiming to address industry challenges like labor shortages and low productivity.

TriOrb is a technology company focused on the development of advanced robotic mobility solutions. It designs and engineers a unique movement system that features a ball-driven omnidirectional mechanism, enabling robots to navigate and transport various objects in manufacturing environments. This innovative technology enhances efficiency and safety on production lines by allowing multiple robots to work together cooperatively, thereby improving the transportation of items that cannot be handled by a single unit. Through its integration of software and hardware, TriOrb aims to provide manufacturers with effective robotic solutions that streamline operations and optimize productivity.

Alumnote provides alumni association management software and a fundraising platform for universities, enabling online administration of alumni networks, loyalty building, and donor acquisition. The company offers digital tools, supports graduate database construction, fundraising operations, and digital transformation services to accelerate the circulation of funds and foster a culture of giving, with activities focused in Japan.

Oxford Quantum Circuits develops quantum computing technology, aiming to tackle complex challenges such as climate change and drug discovery. Their fully functional quantum computer system enables businesses to explore innovative solutions and address global issues.

Founded in 2018, Obviously AI develops a cloud-based platform that enables users to run complex predictions and analytics on their data by asking natural language questions, without requiring coding knowledge. The platform uses machine learning algorithms to interpret user queries, find relevant data, and generate accurate predictions.

RICOS is a technology company that optimizes manufacturing processes by integrating computer-aided engineering, artificial intelligence, and high-performance computing. It develops simulation technologies and a browser-based design and simulation platform, including an AI algorithm called IsoGCN designed to work with simulation data to enable faster, more interactive design and evaluation. The company aims to advance the use of scientific computing in manufacturing sites and to improve calculation accuracy across workflows, supporting research and development so that advanced simulations can be applied throughout manufacturing.

United Immunity, Co., Ltd. is a research and development company based in Tsu, Japan, specializing in the manufacture and sales of pharmaceuticals with a primary focus on cancer immunotherapy. Founded in November 2017, the company develops innovative nanoparticles and lipid nanoparticles aimed at targeting myeloid cells to treat cancer and infectious diseases. United Immunity's technology enables the delivery of various therapeutic agents directly to macrophages and dendritic cells, facilitating the development of treatments for a range of conditions, including cancer, autoimmune diseases, fibrosis, and infectious diseases.

Peach Cars operates a platform facilitating the buying and selling of vehicles. It aims to provide comprehensive vehicle information and streamlined transactions.

Cellusion is a regenerative medicine company developing induced pluripotent stem cell-derived corneal endothelial cells for the treatment of bullous keratopathy. The company focuses on research, development, manufacturing, and commercial supply of corneal endothelial cell substitutes for transplantation to restore corneal function and vision. Originating from Keio University, Cellusion aims to enable scalable, cell-based therapies by cultivating corneal endothelial cells from iPS sources and delivering them for surgical transplantation. Based in Tokyo, Japan, the company emphasizes advancing regenerative ophthalmology through cell-based therapies that offer less invasive treatment options for patients with endothelial corneal disease.

Violet Therapeutics is a pre-clinical stage biotechnology company focused on drug discovery for central nervous system diseases. The company utilizes innovative platforms that identify, map, and analyze cellular connectomes through barcoded viral tracing, offering insights into cell-cell interactions at a single-cell level. This approach aims to facilitate advancements in the understanding and treatment of neuroinflammation. Co-founded by Mass General Brigham Ventures and researchers from Brigham & Women’s Hospital, Violet Therapeutics is committed to exploring novel therapeutic targets to develop effective treatments for complex neurological conditions.

Tricog Health is a company that specializes in cardiac diagnostic tools aimed at addressing cardiovascular conditions through real-time identification and accurate analysis. Utilizing medical-grade artificial intelligence, Tricog improves cardiac care by bridging gaps in infrastructure, expertise, and efficiency within healthcare systems. The company offers virtual diagnostic tools and services that empower healthcare providers to make timely and precise diagnoses, ultimately enhancing patient outcomes. Tricog's innovative medical device facilitates real-time reporting and analysis of electrocardiography results without the need for additional hardware, ensuring early detection of potentially life-threatening cardiac events.

Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.

X Mile is an HR platform that connects logistics companies with drivers, aiming to address industry challenges like labor shortages and low productivity.

HashPort, founded in 2018, supports new web3 businesses by offering development and financing solutions, including Initial Exchange Offerings (IEOs). The company specializes in creating crypto-asset products such as digital wallets and provides consulting services aimed at digitalizing assets. HashPort also focuses on wallet systems and non-fungible token platforms, helping cryptocurrency exchange firms implement blockchain technologies. Its subsidiary, HashPalette, established in 2020, made notable strides by conducting Japan's first approved IEO, developing a blockchain tailored for NFTs, and operating one of the country's largest NFT marketplaces. In April 2023, HashPort secured over 1.2 billion yen in a Series C funding round involving six underwriters.

PaylessGate is an authentication technology company. Their authentication technology utilizes high speed, high precision position measurement technology to grasp location information and perform personal authentication by connecting bluetooth devices, enabling users to provide personal identification without overlapping identification zones.

SUN METALON specializes in decarbonizing metal manufacturing by offering innovative technology for recycling, refining, and forming metals. Its core innovation lies in efficient heating of metal scraps and chips, reducing energy consumption and impurities, thereby significantly lowering CO₂ emissions compared to traditional methods.

Obniz is a tech company specializing in cloud-based IoT systems. It enables real-time, bi-directional control of sensors, actuators, and machines directly from the cloud without requiring terminal-side software development.

Oxford Quantum Circuits develops quantum computing technology, aiming to tackle complex challenges such as climate change and drug discovery. Their fully functional quantum computer system enables businesses to explore innovative solutions and address global issues.

Wassha Inc. is a provider of renewable energy solutions focused on off-grid areas, primarily in emerging markets. Founded in 2013 and headquartered in Tokyo, Japan, with a branch office in Dar es Salaam, Tanzania, the company specializes in renting devices and offering charging services through its network of kiosks powered by clean energy. Utilizing Internet of Things technology, Wassha enables remote management and monitoring of operations, allowing for real-time tracking of transactions, customer data, and power generation. This innovative approach not only facilitates the growth of local businesses but also supports community development in regions lacking access to electricity. Wassha actively seeks business partners to expand its reach and impact in off-grid communities.

Frontier Field is a venture company that brings the medical and healthcare fields together with the power of IT. It also engaged in the planning, development, sales, and maintenance of the nibyo mobile smartphone exclusively for medical institutions.

OriCiro Genomics is a Japanese biotechnology company founded in 2018, based in Minato-ku. It specializes in developing innovative genome technologies, particularly focusing on cell-free synthesis and amplification of large DNA molecules for synthetic biology applications. The company's core technologies include DNA assembly and circular DNA amplification, which enable the construction of large circular DNA molecules without traditional biological cloning methods. OriCiro Genomics serves life science research and development companies, offering solutions that facilitate advancements in gene therapy, pharmaceuticals, diagnostics, food, and agriculture by leveraging synthetic biology.

Eureka Robotics specializes in developing robotic technology that offers high accuracy and agility. With offices in Singapore, France, and Vietnam, it serves various industries such as healthcare, telecom, automotive, photonics, electronics, optics, and aerospace by automating precision handling, assembly, inspection tasks. Its software and systems enable clients to enhance productivity, reduce costs, and improve safety.

Liminal, formerly known as Feasible, Inc., specializes in battery analytics through its innovative EchoStat platform, which utilizes ultrasound waves to assess the physical properties of batteries. By sending ultrasonic pulses through a battery and analyzing the resulting echoes, Liminal can detect differentials within individual cells, across multiple cells, and even between production lines. This technology allows for real-time insights into the electrical, thermal, and mechanical conditions of battery components, making it particularly valuable for industries such as automotive, residential storage, grid storage, and consumer electronics. Founded in 2015 and headquartered in Emeryville, California, Liminal is positioned to enhance battery performance and reliability through its advanced screening and analytics capabilities.

Bugworks Research Inc. is a biotechnology company focused on developing innovative antibiotics to combat antimicrobial resistance (AMR). Founded in 2014, the company operates from its headquarters in Saratoga, California, with additional offices in Adelaide, Australia, and Bengaluru, India. Bugworks specializes in creating a new class of antibiotic drugs designed to withstand drug resistance, offering products such as GYROX-1, an intravenous solution for critical care infections; GYROX-2, an oral treatment for various infections; and GYROX-3, specifically for cystic fibrosis patients. The company's research platform emphasizes broad-spectrum assets and leverages expertise in cancer biology and immunology to address the challenges posed by drug resistance in healthcare.

Eplane builds and develops electric air transportation systems.

ePlane aims to tackle urban road traffic congestion by introducing innovative flying solutions. Their flagship product aims to provide a safe, sustainable, and affordable flying experience, contributing to a future of urban mobility that is efficient and eco-friendly.

Cellusion is a regenerative medicine company developing induced pluripotent stem cell-derived corneal endothelial cells for the treatment of bullous keratopathy. The company focuses on research, development, manufacturing, and commercial supply of corneal endothelial cell substitutes for transplantation to restore corneal function and vision. Originating from Keio University, Cellusion aims to enable scalable, cell-based therapies by cultivating corneal endothelial cells from iPS sources and delivering them for surgical transplantation. Based in Tokyo, Japan, the company emphasizes advancing regenerative ophthalmology through cell-based therapies that offer less invasive treatment options for patients with endothelial corneal disease.

Forest Co., Ltd. is an e-commerce aggregator focused on identifying and promoting sustainable, high-quality products that embody the essence of Japan. The company employs a technology-driven platform to acquire and support third-party brands, leveraging a specialized team that tailors marketing strategies to the unique attributes of each brand. By utilizing a deep understanding of digital algorithms, Forest optimizes advertising efforts to facilitate growth and enhance the global market presence of its partners.

RICOS is a technology company that optimizes manufacturing processes by integrating computer-aided engineering, artificial intelligence, and high-performance computing. It develops simulation technologies and a browser-based design and simulation platform, including an AI algorithm called IsoGCN designed to work with simulation data to enable faster, more interactive design and evaluation. The company aims to advance the use of scientific computing in manufacturing sites and to improve calculation accuracy across workflows, supporting research and development so that advanced simulations can be applied throughout manufacturing.

Charco Neurotech is a medical technology company focused on creating non-invasive wearable devices aimed at enhancing the quality of life for individuals with Parkinson's disease. The company's primary innovation involves a wearable device that modulates sensory dysfunction, which aids users in improving their movement speed and overall mobility. By addressing specific challenges faced by those living with Parkinson's, Charco Neurotech seeks to empower individuals to maintain a more active and normal lifestyle.

ALGO ARTIS is a software company that specializes in optimizing various aspects of plant operations, including tanking, ship allocation planning, and logistics. By utilizing algorithmic methods and user-friendly artificial intelligence technology, ALGO ARTIS provides a consulting design system aimed at enhancing management and operational efficiency. The company's solutions facilitate the correct selection of technology and processes, allowing businesses to streamline their operations effectively. Through its innovative approach, ALGO ARTIS supports organizations in achieving improved performance and operational optimization.

Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.

OriCiro Genomics is a Japanese biotechnology company founded in 2018, based in Minato-ku. It specializes in developing innovative genome technologies, particularly focusing on cell-free synthesis and amplification of large DNA molecules for synthetic biology applications. The company's core technologies include DNA assembly and circular DNA amplification, which enable the construction of large circular DNA molecules without traditional biological cloning methods. OriCiro Genomics serves life science research and development companies, offering solutions that facilitate advancements in gene therapy, pharmaceuticals, diagnostics, food, and agriculture by leveraging synthetic biology.

VividQ Limited is a technology company based in Cambridge, United Kingdom, specializing in the development of software frameworks for generating, compressing, and transmitting 3D holographic images and video. The company offers a variety of products, including VividQ Capture, an API for converting 3D data into holographic formats, and VividQ Squeeze, a solution for compressing point cloud 3D data. Additionally, VividQ Core enables multi-user interactions with holograms at different focal planes, while VividQ View allows integration of various spatial light modulators into its holographic architecture. VividQ's advanced computational display technology aims to revolutionize digital displays by integrating holographic visuals into consumer electronics, augmented reality, virtual reality, and automotive applications. The company, which was formerly known as Penteract28 Limited before rebranding in 2017, collaborates with leading original equipment manufacturers to enhance user experiences in various sectors, including gaming, immersive simulations, and depth sensing.

PaylessGate is an authentication technology company. Their authentication technology utilizes high speed, high precision position measurement technology to grasp location information and perform personal authentication by connecting bluetooth devices, enabling users to provide personal identification without overlapping identification zones.

EditForce Inc. is a biotechnology company based in Fukuoka, Japan, founded in 2015. It specializes in developing innovative technologies for genome and RNA editing, particularly through the engineering of pentatricopeptide repeat (PPR) proteins. EditForce's advanced tools facilitate the manipulation of nucleic acids, enabling precise editing of DNA and RNA at a genomic scale. This technology is applicable across various fields, including biological research, medicine, agriculture, and bio-production, allowing for the development of drugs and genetically modified seeds. By providing alternative genome editing solutions, EditForce aims to advance scientific research and improve agricultural outcomes.

Founded in Tokyo in 2014, Startbahn operates a blockchain-based platform focused on enhancing the art industry globally. It specializes in issuing blockchain certificates for artwork authentication and traceability via its Startbahn Cert service. Additionally, it develops Startrail, a blockchain infrastructure supporting Startbahn Cert, and collaborates with other companies on joint projects.

Founded in 2018, Obviously AI develops a cloud-based platform that enables users to run complex predictions and analytics on their data by asking natural language questions, without requiring coding knowledge. The platform uses machine learning algorithms to interpret user queries, find relevant data, and generate accurate predictions.

DATAFLUCT is a data science company in Japan that provides data management and machine learning services to address corporate and social issues. Its platform handles the collection, storage, analysis, and utilization of diverse data, enabling businesses to predict outcomes and create value from big data. The company focuses on multimodal data integration and rapid, high-precision data utilization through sustainable algorithms that balance environmental, social, customer, and economic value. It also offers tools such as a satellite imagery search service that broadens access to geospatial data, supporting data-driven decision making.

ImmunoScape develops immune profiling systems and analytical tools to support immunotherapy clinical development. Its Deep Immunomics platform integrates mass cytometry, single-cell sequencing, and proprietary computational analytics to profile immune cells with high resolution and to identify antigen-specific T cells, delivering an online data analysis pipeline. The platform provides reproducible immune profiling information used to understand safety and efficacy of immunotherapies and to identify drug targets across oncology and infectious diseases, applicable throughout research, development, and clinical testing.

Obniz is a tech company specializing in cloud-based IoT systems. It enables real-time, bi-directional control of sensors, actuators, and machines directly from the cloud without requiring terminal-side software development.

HashPort, founded in 2018, supports new web3 businesses by offering development and financing solutions, including Initial Exchange Offerings (IEOs). The company specializes in creating crypto-asset products such as digital wallets and provides consulting services aimed at digitalizing assets. HashPort also focuses on wallet systems and non-fungible token platforms, helping cryptocurrency exchange firms implement blockchain technologies. Its subsidiary, HashPalette, established in 2020, made notable strides by conducting Japan's first approved IEO, developing a blockchain tailored for NFTs, and operating one of the country's largest NFT marketplaces. In April 2023, HashPort secured over 1.2 billion yen in a Series C funding round involving six underwriters.

SWAT Mobility is a developer of advanced vehicle-routing technology that addresses intricate transportation challenges faced by companies, transport operators, and government agencies globally. Utilizing an artificial intelligence algorithm, the company specializes in optimizing route planning for large-scale transportation by enabling vehicle pooling and dynamic route adjustments. This innovative approach has been shown to significantly reduce transportation costs, enhance connectivity within cities, and alleviate traffic congestion. SWAT Mobility has established itself as a leader in the industry, demonstrating superior performance through its smart mobility optimization engine, which positions it well for future advancements in autonomous vehicle technology.

Agara Labs is a technology company based in Bengaluru, India, founded in 2017. It specializes in automating customer support operations for large enterprises through its innovative end-to-end engagement system. The company's solutions leverage advanced technology to process multi-format data—including text, audio, and images—derived from customer interactions via emails, chats, phone calls, and social media in real time. Agara's autonomous voice conversation agent is designed to manage customer support calls without human intervention, particularly serving industries such as financial services, consumer products, and retail. This technology not only enhances the customer experience but also significantly reduces support costs by effectively addressing customer queries and feedback similar to a human agent.

Metcela is a clinical-stage biotechnology company based in Kawasaki, Japan, developing fibroblast-based therapies for heart disease. Its approach uses VCAM-1–positive cardiac fibroblasts derived from a patient’s own heart to repair damaged tissue and reestablish a supportive microenvironment, rather than replacing cells. The lead program, MTC001, aims to restore heart function by promoting natural healing in preclinical studies. Metcela was founded in 2016.

Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.

Japan Data Science Consortium Co. is a Tokyo-based company specializing in artificial intelligence, Internet of Things, and robotic services. Established in 2014, JDSC offers a range of solutions including demand forecasting, predictive maintenance, and digital transformation. The company also focuses on zero re-delivery systems, optical character recognition, and image recognition services. Targeting sectors such as healthcare, education, and retail, JDSC provides comprehensive consulting support that encompasses system construction and organizational process transformation, all aimed at generating tangible profit through the effective use of AI technology.

Epigeneron, Inc. is a biotechnology company based in Chuo, Japan, founded in 2015. The company focuses on the research, development, manufacturing, and marketing of pharmaceutical drugs, particularly in the areas of cancer, dementia, metabolic disorders, and infectious diseases. Epigeneron specializes in drug discovery, offering services that include the development of epigenetic and antimicrobial drugs. The company employs advanced techniques such as chromatin immunoprecipitation to isolate specific genomic regions, thereby facilitating the identification of molecules that interact with these regions. This innovative approach enables the development of gene therapies aimed at treating severe immune diseases and other serious health conditions, including fibrosis and disorders of the central nervous system. Additionally, Epigeneron is involved in the manufacture and sale of research reagents, diagnostic agents, and research equipment, alongside supporting drug discovery efforts through information services and intellectual property transfer.

BionicM is a Tokyo‑based company that develops robotic prostheses for lower‑limb amputees. Its products include powered knee joints and ankle‑foot devices that mimic natural muscle function, allowing users to stand, walk, and climb stairs with reduced effort. The company’s technology was first researched in 2015 at the University of Tokyo’s Information Systems Engineering Laboratory and received support from the Japan Science and Technology Agency in 2016. BionicM was formally established in 2018 and continues to advance high‑performance prosthetic solutions that enhance mobility for people with disabilities.

bitBiome, Inc. is a synthetic biology company based in China, founded in November 2018. It focuses on genome analysis of microorganisms through single-cell technology, utilizing its proprietary database of natural microbial sequences, which is the largest of its kind. The company specializes in enzyme discovery and engineering, offering a variety of services including single-cell genomics, database screening, and wet lab evaluations of target sequences. Additionally, bitBiome aims to develop diagnostics and therapeutic solutions by analyzing microorganisms on a cell-by-cell basis, ultimately contributing to advancements in human health.

Tellus is a technology company that specializes in wireless, non-invasive health monitoring for elderly care facilities. It uses advanced sensor technology to continuously track vital signs and activities, providing real-time insights and alerts to caregivers. This enables better decision-making during emergencies or to prevent issues proactively, enhancing eldercare quality and operational efficiency.

ImmunoScape develops immune profiling systems and analytical tools to support immunotherapy clinical development. Its Deep Immunomics platform integrates mass cytometry, single-cell sequencing, and proprietary computational analytics to profile immune cells with high resolution and to identify antigen-specific T cells, delivering an online data analysis pipeline. The platform provides reproducible immune profiling information used to understand safety and efficacy of immunotherapies and to identify drug targets across oncology and infectious diseases, applicable throughout research, development, and clinical testing.

Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It specializes in digital transformation within the commercial real estate sector, offering a software as a service (SaaS) platform that enhances the flow of information and transactions. Estie provides a range of services, including market research and algorithms for rent estimation, which help clients make informed, data-driven decisions. By leveraging innovative software solutions, Estie aims to unlock the value of the commercial real estate industry, facilitating a more efficient and effective decision-making process for its users.

TXP Medical Inc., established in 2017 and headquartered in Bunkyo, Japan, specializes in developing and selling patient information recording and management systems. The company's primary product is NEXTStage ER, a platform supporting both medical record input and research, along with NSER mobile for voice-command and image OCR-based patient data entry. Additionally, TXP Medical offers Self Assessment System enabling patients to input their own data. These solutions aim to connect medical information across different fronts, fostering data-driven decision-making and improving overall healthcare outcomes.

Bugworks Research Inc. is a biotechnology company focused on developing innovative antibiotics to combat antimicrobial resistance (AMR). Founded in 2014, the company operates from its headquarters in Saratoga, California, with additional offices in Adelaide, Australia, and Bengaluru, India. Bugworks specializes in creating a new class of antibiotic drugs designed to withstand drug resistance, offering products such as GYROX-1, an intravenous solution for critical care infections; GYROX-2, an oral treatment for various infections; and GYROX-3, specifically for cystic fibrosis patients. The company's research platform emphasizes broad-spectrum assets and leverages expertise in cancer biology and immunology to address the challenges posed by drug resistance in healthcare.

Nelumbo is a materials innovation company focused on HVAC efficiency and corrosion resistance. It develops a platform of structural materials and advanced surface coatings, including thin superomnophobic nanocoatings for cooling coils, and designs improved heat exchangers for refrigeration and air conditioning equipment. The coatings aim to reduce frost buildup and defrost downtime, while the heat exchangers target better energy performance and lower maintenance. The company positions its technologies to unlock mass-market opportunities with potential carbon emission and energy-use reductions worldwide. It was founded in 2015 and is based in Menlo Park, California.

Tricog Health is a company that specializes in cardiac diagnostic tools aimed at addressing cardiovascular conditions through real-time identification and accurate analysis. Utilizing medical-grade artificial intelligence, Tricog improves cardiac care by bridging gaps in infrastructure, expertise, and efficiency within healthcare systems. The company offers virtual diagnostic tools and services that empower healthcare providers to make timely and precise diagnoses, ultimately enhancing patient outcomes. Tricog's innovative medical device facilitates real-time reporting and analysis of electrocardiography results without the need for additional hardware, ensuring early detection of potentially life-threatening cardiac events.

OPALai offers AI-driven digital financial products working on commodities and FX markets for pricing, hedging, and trading.

VividQ Limited is a technology company based in Cambridge, United Kingdom, specializing in the development of software frameworks for generating, compressing, and transmitting 3D holographic images and video. The company offers a variety of products, including VividQ Capture, an API for converting 3D data into holographic formats, and VividQ Squeeze, a solution for compressing point cloud 3D data. Additionally, VividQ Core enables multi-user interactions with holograms at different focal planes, while VividQ View allows integration of various spatial light modulators into its holographic architecture. VividQ's advanced computational display technology aims to revolutionize digital displays by integrating holographic visuals into consumer electronics, augmented reality, virtual reality, and automotive applications. The company, which was formerly known as Penteract28 Limited before rebranding in 2017, collaborates with leading original equipment manufacturers to enhance user experiences in various sectors, including gaming, immersive simulations, and depth sensing.

Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.

SWAT Mobility is a developer of advanced vehicle-routing technology that addresses intricate transportation challenges faced by companies, transport operators, and government agencies globally. Utilizing an artificial intelligence algorithm, the company specializes in optimizing route planning for large-scale transportation by enabling vehicle pooling and dynamic route adjustments. This innovative approach has been shown to significantly reduce transportation costs, enhance connectivity within cities, and alleviate traffic congestion. SWAT Mobility has established itself as a leader in the industry, demonstrating superior performance through its smart mobility optimization engine, which positions it well for future advancements in autonomous vehicle technology.

Algal Bio Co., Ltd., established in 2018, is a Japanese company specializing in the research, development, production, and sale of algae and its components. Headquartered in Kashiwa, Japan, the company focuses on extracting rare fatty acids and carotenoids from algae, operating within food processing, importing, exporting, and distributing algae-related ingredients. Algal Bio was founded upon two decades of research from the University of Tokyo, aiming to harness microalgae's potential as functional food ingredients.

Wassha Inc. is a provider of renewable energy solutions focused on off-grid areas, primarily in emerging markets. Founded in 2013 and headquartered in Tokyo, Japan, with a branch office in Dar es Salaam, Tanzania, the company specializes in renting devices and offering charging services through its network of kiosks powered by clean energy. Utilizing Internet of Things technology, Wassha enables remote management and monitoring of operations, allowing for real-time tracking of transactions, customer data, and power generation. This innovative approach not only facilitates the growth of local businesses but also supports community development in regions lacking access to electricity. Wassha actively seeks business partners to expand its reach and impact in off-grid communities.

Retrieva is a Tokyo-based developer of AI software for call centers, combining natural language processing and machine learning to analyze inquiries and assist with responses for enterprise clients. The company focuses on research, development, and ongoing support of ML-driven software, and its product family includes Talk Coordinator, an operator software solution; Voice Visualizer, an administrator software solution; and VoC Analyzer, an analysis software solution. Founded in 2016, Retrieva serves organizations seeking scalable, AI-powered customer service solutions.

Adacotech is a company focused on the development and manufacturing of advanced video surveillance systems and anomaly detection software. It offers a unique system that utilizes proprietary algorithms to monitor events continuously for 24 hours while maintaining real-time performance. Adacotech's technology incorporates capabilities for product inspection and abnormality detection in manufacturing processes, as well as the inspection of social infrastructure. By leveraging inputs from images, videos, sounds, and sensors, the company's solutions enable clients to conduct primary screenings effectively. The product development process is managed in-house, ensuring that all aspects, from the source technology to the application programming interface, are controlled by Adacotech.

Mujin is a Tokyo-based company that develops intelligent robot controllers and factory automation solutions for industrial robotics. It provides a universal controller platform that integrates motion planning with machine vision and programmable logic controllers to automate heavy and repetitive tasks in logistics and manufacturing. The company offers products such as Mujin Controller Sim, a platform for programming industrial robots; Mujin Scanner, which creates 3D models of objects or environments; Pick Worker, a bin-picking system with real-time motion planning; and Laser Worker, a laser cutting system powered by motion planning. In addition to hardware and software tools, Mujin supplies services in robot and controller design, teaching and simulation, legacy-system support, and system integration. Its technology focuses on optimizing offline motions and enabling real-time operation across complex workflows, reducing dependence on manual handling in dynamic industrial settings.

OriCiro Genomics is a Japanese biotechnology company founded in 2018, based in Minato-ku. It specializes in developing innovative genome technologies, particularly focusing on cell-free synthesis and amplification of large DNA molecules for synthetic biology applications. The company's core technologies include DNA assembly and circular DNA amplification, which enable the construction of large circular DNA molecules without traditional biological cloning methods. OriCiro Genomics serves life science research and development companies, offering solutions that facilitate advancements in gene therapy, pharmaceuticals, diagnostics, food, and agriculture by leveraging synthetic biology.

Founded in Tokyo in 2014, Startbahn operates a blockchain-based platform focused on enhancing the art industry globally. It specializes in issuing blockchain certificates for artwork authentication and traceability via its Startbahn Cert service. Additionally, it develops Startrail, a blockchain infrastructure supporting Startbahn Cert, and collaborates with other companies on joint projects.

EditForce Inc. is a biotechnology company based in Fukuoka, Japan, founded in 2015. It specializes in developing innovative technologies for genome and RNA editing, particularly through the engineering of pentatricopeptide repeat (PPR) proteins. EditForce's advanced tools facilitate the manipulation of nucleic acids, enabling precise editing of DNA and RNA at a genomic scale. This technology is applicable across various fields, including biological research, medicine, agriculture, and bio-production, allowing for the development of drugs and genetically modified seeds. By providing alternative genome editing solutions, EditForce aims to advance scientific research and improve agricultural outcomes.

Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It specializes in digital transformation within the commercial real estate sector, offering a software as a service (SaaS) platform that enhances the flow of information and transactions. Estie provides a range of services, including market research and algorithms for rent estimation, which help clients make informed, data-driven decisions. By leveraging innovative software solutions, Estie aims to unlock the value of the commercial real estate industry, facilitating a more efficient and effective decision-making process for its users.

BionicM is a Tokyo‑based company that develops robotic prostheses for lower‑limb amputees. Its products include powered knee joints and ankle‑foot devices that mimic natural muscle function, allowing users to stand, walk, and climb stairs with reduced effort. The company’s technology was first researched in 2015 at the University of Tokyo’s Information Systems Engineering Laboratory and received support from the Japan Science and Technology Agency in 2016. BionicM was formally established in 2018 and continues to advance high‑performance prosthetic solutions that enhance mobility for people with disabilities.

PharmaBio Corporation is a healthcare company specializing in the contract development and manufacturing of cellular and tissue-based products. Founded in 1978 and headquartered in Nagoya, Japan, with an administrative branch in Tokyo, the company focuses on the development of cell-based investigational new drugs and offers a range of services including microbial safety testing, specimen storage, and genetic testing for pathogenic viruses. PharmaBio operates a GMP-compliant facility for the storage of cell-based drugs and test specimens, ensuring high standards of safety and quality. Additionally, the company provides strategic development consultation to support regulatory processes in cell and tissue-based medicine, aiming to enhance medical and social progress through its innovative products and services.

bitBiome, Inc. is a synthetic biology company based in China, founded in November 2018. It focuses on genome analysis of microorganisms through single-cell technology, utilizing its proprietary database of natural microbial sequences, which is the largest of its kind. The company specializes in enzyme discovery and engineering, offering a variety of services including single-cell genomics, database screening, and wet lab evaluations of target sequences. Additionally, bitBiome aims to develop diagnostics and therapeutic solutions by analyzing microorganisms on a cell-by-cell basis, ultimately contributing to advancements in human health.

Obniz is a tech company specializing in cloud-based IoT systems. It enables real-time, bi-directional control of sensors, actuators, and machines directly from the cloud without requiring terminal-side software development.

ImmunoScape develops immune profiling systems and analytical tools to support immunotherapy clinical development. Its Deep Immunomics platform integrates mass cytometry, single-cell sequencing, and proprietary computational analytics to profile immune cells with high resolution and to identify antigen-specific T cells, delivering an online data analysis pipeline. The platform provides reproducible immune profiling information used to understand safety and efficacy of immunotherapies and to identify drug targets across oncology and infectious diseases, applicable throughout research, development, and clinical testing.

Socium Inc. is a Japan-based company specializing in AI-powered drug discovery and development. It focuses on creating first-in-class small molecules and has a diverse development portfolio that targets over 23 diseases, including oncology and rare diseases. Utilizing a systems biology approach, Socium leverages advanced algorithms and machine learning to streamline the traditional drug discovery process by employing an in-silico system. This innovative method allows the company to identify drug discovery targets more quickly, often within a few months. Additionally, Socium analyzes a wide array of omics data to profile entire diseases rather than concentrating solely on related compounds, which enhances the efficacy and breadth of its research efforts. By integrating drug repositioning strategies, Socium also seeks to uncover new therapeutic uses for existing commercial drugs, thereby contributing to advancements in healthcare.

Locix, Inc. specializes in developing advanced technology products and services aimed at enhancing spatial and contextual awareness for smart homes and commercial applications. The company offers a range of solutions, including the Locix HD Vision, which provides visual insights for monitoring and analysis, and the Locix Local Positioning System, a comprehensive solution that delivers precise location determination for Wi-Fi-enabled devices. Additional offerings include SmartDock, which utilizes AI for real-time monitoring of loading and unloading efficiencies, and SmartLPS, which digitizes and analyzes operations in warehouses. Locix also provides remote monitoring solutions applicable to various environments such as warehouses and construction sites, as well as a contact tracing solution for COVID-19. Founded in 2015 and based in Silicon Valley, Locix aims to deliver actionable insights through the integration of location, visual, and sensor data with advanced analytics. The company was previously known as Dragonfly Technology Inc. before rebranding in 2017.

Founded in 2018, Neural Pocket specializes in developing proprietary AI technologies for image and video detection, classification, and behavior analysis. The company offers services for smart city development, facility management, digital signage, and fashion trend analysis.

Bugworks Research Inc. is a biotechnology company focused on developing innovative antibiotics to combat antimicrobial resistance (AMR). Founded in 2014, the company operates from its headquarters in Saratoga, California, with additional offices in Adelaide, Australia, and Bengaluru, India. Bugworks specializes in creating a new class of antibiotic drugs designed to withstand drug resistance, offering products such as GYROX-1, an intravenous solution for critical care infections; GYROX-2, an oral treatment for various infections; and GYROX-3, specifically for cystic fibrosis patients. The company's research platform emphasizes broad-spectrum assets and leverages expertise in cancer biology and immunology to address the challenges posed by drug resistance in healthcare.

Founded in Tokyo, Japan in 2015, AI Inside specializes in software development and artificial intelligence. It offers DX Suite, an AI-powered Optical Character Recognition (OCR) platform, transforming information into digital data to enhance productivity.

Nohla Therapeutics, Inc., established in 2015 and headquartered in Seattle, Washington, specializes in developing and manufacturing ex vivo expanded universal donor cellular therapies. The company's core technology enables the expansion of key cancer-fighting cells from umbilical cord blood, eliminating the need for HLA matching. Nohla offers programs such as Natural Killer (NK) cell therapy and Dilanubicel, a universal donor hematopoietic stem and progenitor cell product used for treating chemotherapy-induced neutropenia and other indications. Its products are manufactured and cryopreserved in advance, ensuring immediate availability for patient treatment.

Founded in Tokyo in 2014, Startbahn operates a blockchain-based platform focused on enhancing the art industry globally. It specializes in issuing blockchain certificates for artwork authentication and traceability via its Startbahn Cert service. Additionally, it develops Startrail, a blockchain infrastructure supporting Startbahn Cert, and collaborates with other companies on joint projects.

Elixirgen Therapeutics, LLC is a biotechnology company based in Baltimore, Maryland, that specializes in developing stem cell therapies aimed at curing various diseases, including aging-associated conditions and syndromes such as Alzheimer's disease. Founded in 2017, the company utilizes its proprietary ZSCAN4 protein, which enhances the developmental potential of embryonic stem cells and reactivates early embryonic genes during the production of induced pluripotent stem cells. Elixirgen Therapeutics focuses on regenerative and rejuvenative medicine by conducting research in both fundamental science and practical applications of its technologies. The company operates within the Science + Technology Park at Johns Hopkins, providing a conducive research environment for its scientists. By leveraging the intellectual property and therapy-related assets inherited from its parent company, Elixirgen, LLC, Elixirgen Therapeutics aims to create innovative protein-based therapies that target chronic telomere diseases and improve overall body immunity.

Fressets, Inc., established in 2017 and based in Tokyo, Japan, specializes in developing cryptocurrency wallet systems for virtual currency exchanges. The company's core business is an enterprise wallet management (EWM) system, primarily serving cryptocurrency exchanges and custodians. This system employs multisignature addresses and secure hardware for key storage, ensuring robust security against hacker threats. It combines the advantages of secure cold wallets and convenient hot wallets, providing clients with a balance of security and scalability for smooth cryptocurrency transactions.

MiRTeL Co., Ltd is a healthcare technology company based in Hiroshima, Japan, founded in 2012. The company specializes in gene testing services, providing clinical testing aimed at early disease detection, including cancer and genetic disorders. In addition to its testing services, MiRTeL distributes supplements to promote overall health. By facilitating health examinations and enabling healthcare organizations to identify health issues at an early stage, MiRTeL contributes to improved patient longevity and reduced medical expenses.

Founded in 2014, Aidemy offers an online platform for individuals to learn artificial intelligence programming and for businesses to leverage AI technology using their own data. Its services include practical blockchain applications, supporting DX human resource development, problem selection, proof-of-concept development, and operation.